These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10228142)

  • 21. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma.
    Boonsawat W; Charoenratanakul S; Pothirat C; Sawanyawisuth K; Seearamroongruang T; Bengtsson T; Brander R; Selroos O
    Respir Med; 2003 Sep; 97(9):1067-74. PubMed ID: 14509562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible airway obstruction.
    Carlsson LG; Arweström E; Friberg K; Källén A; Lunde H; Löfdahl CG
    Allergy; 1998 Jul; 53(7):712-5. PubMed ID: 9700042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salbutamol via Easyhaler is at least as effective as salbutamol via Turbuhaler in the treatment of histamine-induced bronchoconstriction.
    Zetterström O; Lähelmä S; Keski-karhu J; Silvasti M; Ostling-kulling E; Ahonen A
    Respir Med; 2000 Nov; 94(11):1097-102. PubMed ID: 11127498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the inhalation device affect the bronchodilatory dose response curve of salbutamol in asthma and chronic obstructive pulmonary disease patients?
    Broeders ME; Molema J; Hop WC; Vermue NA; Folgering HT
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):449-55. PubMed ID: 12920494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD.
    Cazzola M; Centanni S; Regorda C; di Marco F; di Perna F; Carlucci P; Boveri B; Santus P
    Pulm Pharmacol Ther; 2001; 14(1):41-5. PubMed ID: 11162418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formoterol Turbuhaler as reliever medication in patients with acute asthma.
    Rubinfeld AR; Scicchitano R; Hunt A; Thompson PJ; Van Nooten A; Selroos O
    Eur Respir J; 2006 Apr; 27(4):735-41. PubMed ID: 16455838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
    Miller CJ; Senn S; Mezzanotte WS
    Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer.
    Seppälä OP; Herrala J; Hedman J; Alanko K; Liipo K; Terho E; Pietinalho A; Nyholm JE; Nieminen MM
    Respir Med; 1998 Mar; 92(3):578-83. PubMed ID: 9692126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the bronchodilator effect of salbutamol inhaled via Turbuhaler as two consecutive doses or as two divided doses at different time intervals.
    Lindbladh C; Smith P; Jackson L; Begishvilli B; Jamieson A; Holgate ST
    Int J Pharm; 1999 Nov; 190(1):57-62. PubMed ID: 10528097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma.
    LaForce C; Prenner BM; Andriano K; Lavecchia C; Yegen U
    J Asthma; 2005 Mar; 42(2):101-6. PubMed ID: 15871441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhalation device influences lung deposition and bronchodilating effect of terbutaline.
    Borgström L; Derom E; Ståhl E; Wåhlin-Boll E; Pauwels R
    Am J Respir Crit Care Med; 1996 May; 153(5):1636-40. PubMed ID: 8630614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
    Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
    Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma.
    Fishwick D; Bradshaw L; Macdonald C; Beasley R; Gash D; Bengtsson T; Bondesson E; Borgström L
    Am J Respir Crit Care Med; 2001 Feb; 163(2):474-7. PubMed ID: 11179125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onset of action following formoterol Turbuhaler and salbutamol pMDI in reversible chronic airway obstruction.
    Cazzola M; Grella E; Matera MG; Mazzarella G; Marsico SA
    Pulm Pharmacol Ther; 2002; 15(2):97-102. PubMed ID: 12090782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agreement between two methods for assessing bioequivalence of inhaled salbutamol.
    Lavorini F; Geri P; Camiciottoli G; Pistolesi M; Fontana GA
    Pulm Pharmacol Ther; 2008; 21(2):380-4. PubMed ID: 17997115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.